1, the use of antiepileptic drugs
In the fourth issue of Drug Safety Update, released by the British Medicines and Health Products Administration (MHRA) in October 2013 10, the possible risks of switching between different antiepileptic drugs were also suggested. According to MHRA, the characteristics of different antiepileptic drugs are very different, and switching between products of different manufacturers may lead to adverse reactions or epilepsy out of control.
Epilepsy: Scientific and standardized treatment is the king.
Epilepsy is a chronic brain disease. At present, there are 9 million epileptic patients in China, with 400,000 new cases every year, most of whom are children and adolescents. Seizures have brought great psychological pressure and serious social consequences to patients. To control the seizure and strive for the cure of the disease, we mainly rely on the repair and regeneration of neuropeptide and take antiepileptic drugs. However, about 30% patients are not satisfied with the current drug treatment. After antiepileptic treatment, epileptic patients easily stop taking drugs, change medicine unreasonably and abuse drugs, which will inevitably lead to serious consequences. The treatment of epilepsy must be scientific and standardized.
In addition, in the treatment of epilepsy, we must not listen to advertisements casually, abuse some Chinese patent medicines or use large doses of various drugs. This will cause serious consequences and bring unnecessary losses to the family economy. Because some so-called Chinese patent medicines for treating epilepsy often contain a variety of western medicine ingredients, patients do not know the ingredients or the dosage when taking them, which is very dangerous. Secondly, antiepileptic therapy is a very long process, and patients must persevere.
CHM: Antiepileptic drugs can be divided into three categories. Doctors should be careful when prescribing medicine to patients.
CHM classifies antiepileptic drugs into three categories according to their characteristics, therapeutic index, solubility and absorption, which helps doctors and patients to determine whether it is necessary to maintain the products of a particular manufacturer.
1 Class: phenytoin sodium, carbamazepine, phenobarbital and primidone.
For these drugs, doctors are advised to ensure that patients keep the products of specific manufacturers.
Class 2: Valproate, Lamotrigine, perampanel, retigabine, rufinamide, clobazam, Clonazepam, Oxcarbazepine, eslicarbazepine, Zonisamide and Topiramate.
For these drugs, we should decide whether it is necessary to continue to use the products of a specific manufacturer according to clinical judgment, and negotiate with patients and/or guardians, taking into account factors such as attack frequency and treatment history.
Class 3: levetiracetam, laconamide, tiagabine, gabapentin, pregabalin, ethosuximide and cowpea.
For these drugs, there is usually no need to maintain the products of specific manufacturers, unless there are special reasons, such as patients' anxiety and the risk of mental disorder or medication errors.
Recurrent attacks: it is the general trend that new technology replaces drug treatment.
At present, drug control is a routine method to treat epilepsy. Side effects and long-term repeated medication make too many people fidget. Everyone can do it by taking medicine on time for one year, but who can guarantee the timely dosage by taking medicine on time 10 years? Some patients who have been taking medicine for ten years began to try "neuropeptide repair technology". After a period of treatment and consolidation, the drug was gradually reduced, and finally the drug was stopped, which made the patient ecstatic! Neuropeptide repair technology can really eliminate the helplessness of patients and make them recover, and this technology will replace traditional medicine and surgical treatment. This technology was developed by authoritative experts at home and abroad, and they have strong power to replace the old technology. In 20 14, Nobel Prize winners were deeply amazed by this technology, and they all said that it would be the general trend for neuropeptide repair and regeneration to replace traditional treatment.
2. Antiepileptic drugs
1, phenytoin sodium, also known as dalun Ding, has strong effect and high curative effect, and has good curative effect on treating grand mal and epileptic seizures, but has no effect on minor seizures, and may even aggravate minor seizures. The drug takes effect slowly, and it usually takes about three or four days to see the effect.
2. Phenobarbital is also an antiepileptic drug, which is used to treat grand mal and epilepsy. The side effects of this medicine are relatively small.
3, ethosuximide, doctors are often used to treat seizures.
4. Phenylsuccinate, an antiepileptic drug used to treat mild absences and psychomotor seizures.
5. Trimethyldiketone is effective in treating minor seizures, but it takes two or three days to take effect, so it is often used to prevent minor seizures.
The antiepileptic drug is phenytoin sodium, which is also the most representative antiepileptic drug. Epilepsy is a disease involving the human nervous system, so it will produce unconscious, uncontrollable and other adverse effects. Epilepsy patients can take medication when they get sick, and antiepileptic drugs are also effective and reliable.